prikaz prve stranice dokumenta Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection
  Preuzmi
PDF 396.25 KB
Znanstveni rad - Izvorni znanstveni rad
Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection
Blood Purification, 52 (2023), 7-8; 642-651. https://doi.org/10.1159/000531356
Premužić, Vedran; Šitum, Ivan; Lovrić, Daniel; Erceg, Ante; Karmelić, Dora; Moguš, Mate; Jurjević, Matija; Nedeljković, Vanja; Mažar, Mirabel; Mihaljević, Slobodan; Villa, Gianluca; Ronco, Claudio

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Premužić, V., Šitum, I., Lovrić, D., Erceg, A., Karmelić, D., Moguš, M. ... Ronco, C. (2023). Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection. Blood Purification, 52. (7-8), 642-651. doi: 10.1159/000531356

Premužić, Vedran, et al. "Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection." Blood Purification, vol. 52, br. 7-8, 2023, str. 642-651. https://doi.org/10.1159/000531356

Premužić, Vedran, Ivan Šitum, Daniel Lovrić, Ante Erceg, Dora Karmelić, Mate Moguš, Matija Jurjević, et al. "Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection." Blood Purification 52, br. 7-8 (2023): 642-651. https://doi.org/10.1159/000531356

Premužić, V., et al. (2023) 'Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection', Blood Purification, 52(7-8), str. 642-651. doi: 10.1159/000531356

Premužić V, Šitum I, Lovrić D, Erceg A, Karmelić D, Moguš M, i sur.. Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection. Blood Purification [Internet]. 2023. [pristupljeno 13.01.2025.];52(7-8):642-651. doi: 10.1159/000531356

V. Premužić, et al., "Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection", Blood Purification, vol. 52, br. 7-8, str. 642-651, 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:598473. [Citirano: 13.01.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:598473
Podaci o radu
Naslov (engleski)Sequential Extracorporeal Blood Purification Is Associated with Prolonged Survival among ICU Patients with COVID-19 and Confirmed Bacterial Superinfection
AutorVedran Premužić
AutorIvan Šitum
AutorDaniel Lovrić
AutorAnte Erceg
AutorDora Karmelić
AutorMate Moguš
AutorMatija Jurjević
AutorVanja Nedeljković
AutorMirabel Mažar
AutorSlobodan Mihaljević
AutorGianluca Villa
AutorClaudio Ronco
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA ANESTEZIOLOGIJU, REANIMATOLOGIJU I INTENZIVNU MEDICINU KIRURŠKIH STRUKA)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Anesteziologija i reanimatologija
Sažetak (engleski)
Introduction: This study investigates the impact of sequential extracorporeal treatments with oXiris® or CytoSorb® plus Seraph-100® on the clinical and laboratory parameters of critically ill COVID-19 patients with bacterial superinfection. Methods: Patients admitted to the intensive care unit with COVID-19, bacterial superinfection, and undergoing blood purification (BP) were enrolled in this prospective, single-center, observational study. "standard BP" with oXiris® or CytoSorb® were used in 35 COVID-19 patients with bacterial infection. Seraph-100® was added in 33 patients when available serially in the same oXiris® circuit or as sequential treatment with CytoSorb® as a sequential BP. Results: A significant reduction in SOFA score 3 days after treatment was observed in patients undergoing sequential BP (11.3 vs. 8.17, p < 0.01) compared to those undergoing "standard BP" (11.0 vs. 10.3, p > 0.05). The difference between the observed and expected mortality rate based on APACHE IV was greater in the sequential BP group (42.4% vs. 81.7%, p < 0.001) than the "standard BP" (74.2% vs. 81.7%, p > 0.05). Patients treated with sequential BP had a longer survival than those treated with "standard BP" (22.4 vs. 18.7 months; p < 0.001). Conclusions: The sequential approach may enhance the positive effect of BP on organ dysfunction among critically ill patients with COVID-19 and bacterial superinfection.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBlood Purification
Brojčani podacivol. 52, br. 7-8, str. 642-651
p-ISSN0253-5068
e-ISSN1421-9735
DOIhttps://doi.org/10.1159/000531356
URN:NBNurn:nbn:hr:105:598473
Datum objave publikacije2023
URL dokumentahttps://karger.com/BPU/article/doi/10.1159/000531356
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-09-24 11:22:37